Sonnerie VC's portfolio of pre-seed and seed healthcare and life sciences companies, including BMI OrganBank, which is advancing room-temperature organ preservation and assessment, beginning with the kidney.

Portfolio

The companies
we back.

We write the first institutional check into university spinouts and founder-led companies in healthcare and life sciences. A look at where our conviction has gone.

Organ preservation · Medical devices

BMI OrganBank

Out of stealth

Room-temperature organ preservation and assessment, beginning with the kidney. BMI OrganBank is rethinking how donor organs are kept viable and evaluated, addressing one of the transplant system's most stubborn losses, the organs that never make it to a patient.

Sonnerie VC invested in January 2026, alongside Mid Atlantic Bio Angels.

Visit BMI OrganBank ↗ Why we backed them → Read the announcement →

From signal to scale.

More to announce, as the signal becomes obvious.

We back companies at the earliest, quietest moment. If you're building in healthcare or life sciences, we'd like to hear it first.

Get in touch →